Skip to main content
Top
Published in: International Cancer Conference Journal 4/2016

01-10-2016 | Case report

Late recurrence of gastric cancer in the ovary and uterine cervix

Authors: Mariko Watanabe, Kiyoshi Hasegawa, Anriko Kanamori, Kaori Kiuchi, Tatsuya Kuno, Nobuaki Kosaka, Ichio Fukasawa, Yasuo Imai

Published in: International Cancer Conference Journal | Issue 4/2016

Login to get access

Abstract

Uterine cervical metastasis from gastric cancer is relatively rare. This is a report of an extremely rare instance of concurrent late gastric-cancer recurrence to the left ovary and the uterine cervix, 11 years after initial treatment. A 53-year-old woman was referred to our hospital with continuous abdominal pain and genital bleeding. Eleven years prior, she had been treated for gastric cancer, pathologically confirmed as stage II poorly differentiated adenocarcinoma with signet-ring cell carcinoma (pT2N1M0). Magnetic resonance imaging results showed a solid mass in the left ovary, about 8 cm in diameter, fixed to the enlarged uterus and displaying slightly high intensity on T1-weighted images and uneven low intensity and enhanced hypervascular areas on T2-weighted images. Cervical biopsy revealed small, round, spindle-shaped tumor cells beneath a normal cervical epithelium. When we did the immunohistochemistry tests, the tumor cells were positive for cytokeratin 5.2, cytokeratin anion exchange protein 1/3, and cytokeratin 7; the cells were negative for cytokeratin 20 and paired-box gene (PAX) 8. This marker pattern was the same as that of her previous gastric cancer; therefore, the tumors of the cervix and left ovary were diagnosed as metastatic gastric cancer. After obtaining informed consent, the patient received transarterial chemoembolization using cisplatin and, subsequently, underwent a modified radical hysterectomy, bilateral salpingo-oophorectomy. Pathological examination revealed an infiltrative pattern with poorly differentiated adenocarcinoma and signet-ring cell carcinoma. The patient received combination chemotherapy with cisplatin and S-1, and she is currently alive 12 months after surgery with no evidence of recurrence. Late recurrence more than 10 years after treatment for primary gastric cancer is extremely rare. Clinicians should be aware of the possibility of metastasis from extrapelvic carcinomas, even in patients treated many years prior to presentation.
Literature
1.
go back to reference Pérez-Montiel D, Serrano-Olvera A, Salazar LC et al (2012) Adenocarcinoma metastatic to the uterine cervix: a case series. J Obstet Gynaecol Res 38:541–549CrossRefPubMed Pérez-Montiel D, Serrano-Olvera A, Salazar LC et al (2012) Adenocarcinoma metastatic to the uterine cervix: a case series. J Obstet Gynaecol Res 38:541–549CrossRefPubMed
2.
go back to reference Lemoine NR, Hall PA (1986) Epithelial tumors metastatic to the uterine cervix. A study of 33 cases and review of the literature. Cancer 57:2002–2005CrossRefPubMed Lemoine NR, Hall PA (1986) Epithelial tumors metastatic to the uterine cervix. A study of 33 cases and review of the literature. Cancer 57:2002–2005CrossRefPubMed
3.
go back to reference Shiraishi N, Inomata M, Osawa N et al (2000) Early and late recurrence after gastrectomy for gastric carcinoma. Univariate and multivariate analyses. Cancer 89(2):255–261CrossRefPubMed Shiraishi N, Inomata M, Osawa N et al (2000) Early and late recurrence after gastrectomy for gastric carcinoma. Univariate and multivariate analyses. Cancer 89(2):255–261CrossRefPubMed
5.
go back to reference Piver MS, Rutledge F, Smith JP (1974) Five classes of extended hysterectomy for women with cervical cancer. Obstet Gynecol 44:265–272PubMed Piver MS, Rutledge F, Smith JP (1974) Five classes of extended hysterectomy for women with cervical cancer. Obstet Gynecol 44:265–272PubMed
6.
go back to reference Yamamoto T, Mori T, Matsushima H (2014) Late, isolated metastasis from poorly differentiated gastric cancer to the uterine cervix. Gynecol Oncol Case Rep 8:17–20CrossRefPubMedPubMedCentral Yamamoto T, Mori T, Matsushima H (2014) Late, isolated metastasis from poorly differentiated gastric cancer to the uterine cervix. Gynecol Oncol Case Rep 8:17–20CrossRefPubMedPubMedCentral
7.
go back to reference Yokoyama Y, Sato S, Futagami M (2000) Solitary metastasis to the uterine cervix from the early gastric cancer: a case report. Eur J Gynaecol Oncol 21:469–471PubMed Yokoyama Y, Sato S, Futagami M (2000) Solitary metastasis to the uterine cervix from the early gastric cancer: a case report. Eur J Gynaecol Oncol 21:469–471PubMed
8.
go back to reference Laury AR, Perets R, Piao H et al (2011) A comprehensive analysis of PAX8 expression in human epithelial tumors. Am J Surg Pathol 35:816–826CrossRefPubMed Laury AR, Perets R, Piao H et al (2011) A comprehensive analysis of PAX8 expression in human epithelial tumors. Am J Surg Pathol 35:816–826CrossRefPubMed
9.
go back to reference Liang L, Zheng W, Liu J et al (2016) Assessment of the utility of PAX8 immunohistochemical stain in diagnosing endocervical glandular lesions. Arch Pathol Lab Med 140:148–152CrossRefPubMed Liang L, Zheng W, Liu J et al (2016) Assessment of the utility of PAX8 immunohistochemical stain in diagnosing endocervical glandular lesions. Arch Pathol Lab Med 140:148–152CrossRefPubMed
10.
go back to reference Yamada Y, Higuchi K, Nishikawa K et al (2015) Phase III study comparing oxaliplatin plus S-1 with cisplatin plus S-1 in chemotherapy-naïve patients with advanced gastric cancer. Ann Oncol 26:141–148CrossRefPubMed Yamada Y, Higuchi K, Nishikawa K et al (2015) Phase III study comparing oxaliplatin plus S-1 with cisplatin plus S-1 in chemotherapy-naïve patients with advanced gastric cancer. Ann Oncol 26:141–148CrossRefPubMed
Metadata
Title
Late recurrence of gastric cancer in the ovary and uterine cervix
Authors
Mariko Watanabe
Kiyoshi Hasegawa
Anriko Kanamori
Kaori Kiuchi
Tatsuya Kuno
Nobuaki Kosaka
Ichio Fukasawa
Yasuo Imai
Publication date
01-10-2016
Publisher
Springer Japan
Published in
International Cancer Conference Journal / Issue 4/2016
Electronic ISSN: 2192-3183
DOI
https://doi.org/10.1007/s13691-016-0259-5

Other articles of this Issue 4/2016

International Cancer Conference Journal 4/2016 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine